Drawing for TUMORSCAN

USPTO serial 79246888

TUMORSCAN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BULLOFF, TOBY ELLEN
Law office
TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TUMORSCAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Kits comprising test reagents for medical diagnosis, and modified comet assays, using liquid biopsy or blood sampling for clinical diagnostic tests based on DNA quantificationACTIVE—
009Software intended to be integrated with reader-analyzers for observation, analysis and characterization of cells extracted from liquid or tissue biopsies, or blood sampling, for clinical diagnostic tests, automated, high-throughput, based on the quantification of DNA, namely, the measurement of damages and their repairACTIVE—
010Medical devices, namely, reader-analyzers comprising a photonic microscope for observation, analysis and characterization of cells extracted from a blood sample, liquid or tissue biopsies, for automated high-throughput clinical diagnostic tests based on DNA quantification, namely, the measurement of damages and their repair related to a tumor pathologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2020FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 5, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 26, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 22, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 6, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 6, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 26, 2019MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 26, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 16, 2019RFNTREFUSAL PROCESSED BY IB—
Jan 26, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 26, 2019RFRRREFUSAL PROCESSED BY MPU—
Jan 15, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 14, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 11, 2019DOCKASSIGNED TO EXAMINER—
Dec 18, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 12, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance